Search results
Showing 2476 to 2490 of 9044 results
Awaiting development Reference number: GID-TA10833 Expected publication date: TBC
Tideglusib for treating congenital or childhood onset myotonic dystrophy [ID3915]
Awaiting development Reference number: GID-TA10791 Expected publication date: TBC
Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]
Awaiting development Reference number: GID-TA10776 Expected publication date: TBC
Sarizotan for the treatment of respiratory symptoms associated with Rett syndrome [ID1506]
Awaiting development Reference number: GID-TA10662 Expected publication date: TBC
Awaiting development Reference number: GID-QS10038 Expected publication date: TBC
Awaiting development Reference number: GID-TA12466 Expected publication date: TBC
In development Reference number: GID-HTG10527 Expected publication date: TBC
Upadacitinib for treating moderately to severely active systemic lupus erythematosus [TSID12366]
Awaiting development Reference number: GID-TA12021 Expected publication date: TBC
Semaglutide for managing overweight and obesity in children 6 to 11 years [TSID12381]
Awaiting development Reference number: GID-TA12020 Expected publication date: TBC
Odevixibat for treating biliary atresia in children following Kasai hepatoportoenterostomy [ID6627]
Awaiting development Reference number: GID-TA11526 Expected publication date: TBC
Topic prioritisation
Image-guided high intensity focused ultrasound to treat breast cancer
Topic prioritisation
Palbociclib for treating high-risk early breast cancer after neoadjuvant chemotherapy [ID3846]
Awaiting development Reference number: GID-TA10723 Expected publication date: TBC
Atezolizumab for adjuvant treatment of resected high-risk muscle-invasive urothelial cancer [ID2730]
In development Reference number: GID-TA10623 Expected publication date: TBC